Obesity Rules. Investors Find US biotech Hard to Swallow

Investors looking for growth stocks are very active in the biotech and pharmaceutical sector, particularly those that focus on fat fighting cures. We will look to see who they predict to be the company to benefit most from obesity cures.

We look at Eli Lilly (LLY), Arena Pharmaceuticals (ARNA), Vivus (VVUS) and Orexigen Therapeutics (OREX)

Click here to read the report